home / stock / itci / itci quote
Last: | $72.80 |
---|---|
Change Percent: | 0.93% |
Open: | $72.27 |
Close: | $72.13 |
High: | $73.52 |
Low: | $71.66 |
Volume: | 197,285 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$72.8 | $72.27 | $72.13 | $73.52 | $71.66 | 197,285 | 04-26-2024 |
$72.13 | $72.46 | $72.13 | $72.78 | $71.35 | 658,771 | 04-25-2024 |
$73.12 | $73.74 | $73.12 | $74.12 | $72.41 | 725,981 | 04-24-2024 |
$74.01 | $75.06 | $74.01 | $76.89 | $73.6884 | 825,656 | 04-23-2024 |
$74.54 | $73.68 | $74.54 | $75.14 | $72.02 | 1,927,853 | 04-22-2024 |
$72.37 | $72.31 | $72.37 | $74.56 | $70.93 | 2,189,254 | 04-19-2024 |
$72 | $74.4 | $72 | $75.075 | $71.205 | 4,711,039 | 04-18-2024 |
$76.69 | $79 | $76.69 | $83.25 | $76.5 | 2,862,199 | 04-17-2024 |
$79.84 | $75.29 | $79.84 | $84.89 | $75 | 7,381,356 | 04-16-2024 |
$64.76 | $65.71 | $64.76 | $66.05 | $64.155 | 503,322 | 04-15-2024 |
$65.88 | $68.04 | $65.88 | $68.67 | $64.84 | 586,929 | 04-12-2024 |
$67.97 | $67.89 | $67.97 | $68.68 | $66.53 | 431,105 | 04-11-2024 |
$67.28 | $67.12 | $67.28 | $68.12 | $66.53 | 541,589 | 04-10-2024 |
$68.62 | $68.07 | $68.62 | $69.015 | $67.9 | 493,243 | 04-09-2024 |
$67.7 | $68.74 | $67.7 | $68.905 | $67.325 | 376,861 | 04-08-2024 |
$68.44 | $67.29 | $68.44 | $69.5 | $67.02 | 702,125 | 04-05-2024 |
$67.21 | $68.49 | $67.21 | $69.33 | $66.61 | 661,496 | 04-04-2024 |
$67.32 | $66.28 | $67.32 | $68.73 | $65.99 | 586,293 | 04-03-2024 |
$66.67 | $66.94 | $66.67 | $67.55 | $65.93 | 502,775 | 04-02-2024 |
$68.27 | $69.2 | $68.27 | $69.36 | $67.73 | 367,886 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Intra-Cellular Therapies Inc. Company Name:
ITCI Stock Symbol:
NASDAQ Market:
Intra-Cellular Therapies Inc. Website:
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ("Intra-Cellular Therapies"), a biopharmaceutical com...
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that...
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street...